175 related articles for article (PubMed ID: 17922632)
1. The therapeutic role of targeting protein kinase C in solid and hematologic malignancies.
Podar K; Raab MS; Chauhan D; Anderson KC
Expert Opin Investig Drugs; 2007 Oct; 16(10):1693-707. PubMed ID: 17922632
[TBL] [Abstract][Full Text] [Related]
2. Potential role of PKC inhibitors in the treatment of hematological malignancies.
Mischiati C; Melloni E; Corallini F; Milani D; Bergamini C; Vaccarezza M
Curr Pharm Des; 2008; 14(21):2075-84. PubMed ID: 18691117
[TBL] [Abstract][Full Text] [Related]
3. Preclinical and clinical development of novel agents that target the protein kinase C family.
Serova M; Ghoul A; Benhadji KA; Cvitkovic E; Faivre S; Calvo F; Lokiec F; Raymond E
Semin Oncol; 2006 Aug; 33(4):466-78. PubMed ID: 16890801
[TBL] [Abstract][Full Text] [Related]
4. The pros and cons of targeting protein kinase C (PKC) in the management of cancer patients.
Leskow FC; Krasnapolski MA; Urtreger AJ
Curr Pharm Biotechnol; 2011 Nov; 12(11):1961-73. PubMed ID: 21470133
[TBL] [Abstract][Full Text] [Related]
5. Atypical protein kinase Cι as a human oncogene and therapeutic target.
Parker PJ; Justilien V; Riou P; Linch M; Fields AP
Biochem Pharmacol; 2014 Mar; 88(1):1-11. PubMed ID: 24231509
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C in cancer: The top five unanswered questions.
Cooke M; Magimaidas A; Casado-Medrano V; Kazanietz MG
Mol Carcinog; 2017 Jun; 56(6):1531-1542. PubMed ID: 28112438
[TBL] [Abstract][Full Text] [Related]
7. Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside.
Bosco R; Melloni E; Celeghini C; Rimondi E; Vaccarezza M; Zauli G
Mini Rev Med Chem; 2011 Mar; 11(3):185-99. PubMed ID: 21534929
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C as a drug target: implications for drug or diet prevention and treatment of cancer.
Carter CA
Curr Drug Targets; 2000 Sep; 1(2):163-83. PubMed ID: 11465069
[TBL] [Abstract][Full Text] [Related]
9. Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.
Beck JF; Brügger D; Brischwein K; Liu C; Bader P; Niethammer D; Gekeler V
Jpn J Cancer Res; 2001 Aug; 92(8):896-903. PubMed ID: 11509123
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C isozymes as potential targets for anticancer therapy.
Hofmann J
Curr Cancer Drug Targets; 2004 Mar; 4(2):125-46. PubMed ID: 15032665
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression.
Isakov N
Semin Cancer Biol; 2018 Feb; 48():36-52. PubMed ID: 28571764
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C inhibitors as novel anticancer drugs.
Goekjian PG; Jirousek MR
Expert Opin Investig Drugs; 2001 Dec; 10(12):2117-40. PubMed ID: 11772309
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C: perfectly balanced.
Newton AC
Crit Rev Biochem Mol Biol; 2018 Apr; 53(2):208-230. PubMed ID: 29513138
[TBL] [Abstract][Full Text] [Related]
14. The role of protein kinase C and novel phorbol ester receptors in tumor cell invasion and metastasis (Review).
Gomez DE; Skilton G; Alonso DF; Kazanietz MG
Oncol Rep; 1999; 6(6):1363-70. PubMed ID: 10523713
[TBL] [Abstract][Full Text] [Related]
15. Tobacco smoke tumor promoters, catechol and hydroquinone, induce oxidative regulation of protein kinase C and influence invasion and metastasis of lung carcinoma cells.
Gopalakrishna R; Chen ZH; Gundimeda U
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12233-7. PubMed ID: 7991611
[TBL] [Abstract][Full Text] [Related]
16. Role of ellagic acid in regulation of apoptosis by modulating novel and atypical PKC in lymphoma bearing mice.
Mishra S; Vinayak M
BMC Complement Altern Med; 2015 Aug; 15():281. PubMed ID: 26276710
[TBL] [Abstract][Full Text] [Related]
17. Modulation of protein kinase C in antitumor treatment.
Hofmann J
Rev Physiol Biochem Pharmacol; 2001; 142():1-96. PubMed ID: 11190577
[TBL] [Abstract][Full Text] [Related]
18. The role of protein kinase C-alpha in hematologic malignancies.
Lahn M; Sundell K; Köhler G
Acta Haematol; 2006; 115(1-2):1-8. PubMed ID: 16424642
[TBL] [Abstract][Full Text] [Related]
19. Enzastaurin.
Chen YB; LaCasce AS
Expert Opin Investig Drugs; 2008 Jun; 17(6):939-44. PubMed ID: 18491994
[TBL] [Abstract][Full Text] [Related]
20. Targeting the protein kinase C family: are we there yet?
Mackay HJ; Twelves CJ
Nat Rev Cancer; 2007 Jul; 7(7):554-62. PubMed ID: 17585335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
